CFDA approval has been given too much valuation in Australia.
Chinese infant formula company, BeingMate (Market cap: A$1b) which is in partnership with Fonterra (is also second largest shareholder of BeingMate), received first CFDA approval last August, now BeingMate has received CFDA approval for 39 infant formula formulations(/steps), but it’s valued at A$1b.
At 100% basis, JAT was valued over $200m at 23c/share, it’s too much imo.
JAT Chart & TA Discussions, page-668
-
- There are more pages in this discussion • 347 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add JAT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.3¢ |
Change
-0.038(5.68%) |
Mkt cap ! $51.83M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 66.0¢ | 60.0¢ | $49.53K | 78.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 60.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 1834 | 1 |
View Market Depth
| Last trade - 14.52pm 28/08/2024 (20 minute delay) ? |
| JAT (ASX) Chart |